These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1186921)

  • 21. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver.
    Stäubli W; Bentley P; Bieri F; Fröhlich E; Waechter F
    Carcinogenesis; 1984 Jan; 5(1):41-6. PubMed ID: 6140087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.
    Fleischner G; Meijer DK; Levine WG; Gatmaitan Z; Gluck R; Arias IM
    Biochem Biophys Res Commun; 1975 Dec; 67(4):1401-7. PubMed ID: 812503
    [No Abstract]   [Full Text] [Related]  

  • 24. Physiologic determinants of biliary calcium secretion in the dog.
    Cummings SA; Hofmann AF
    Gastroenterology; 1984 Sep; 87(3):664-73. PubMed ID: 6146552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of atropine on bile flow and biliary excretion of 3H-ouabain in the isolated perfused rat liver.
    Nevasaari K; Alakare B; Kärki NT
    Pharmacology; 1977; 15(1):55-64. PubMed ID: 840890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin.
    Delzenne NM; Taper HS; Roberfroid M
    Arch Toxicol; 1994; 68(6):394-7. PubMed ID: 8092930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choleresis associated with metabolism and biliary excretion of diethyl maleate in the rat and dog.
    Barnhart JL; Combes B
    J Pharmacol Exp Ther; 1978 Sep; 206(3):614-23. PubMed ID: 702325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat.
    Jorritsma J; Meerman JH; Vonk RJ; Mulder GJ
    Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats.
    Lévy P; Dumont M; Brissot P; Letreut A; Favier A; Deugnier Y; Erlinger S
    Gastroenterology; 1991 Dec; 101(6):1673-9. PubMed ID: 1955132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased hepatotoxicity of carbon tetrachloride by the hypolipidemic drug nafenopin in rats.
    Charpentier D; Tuchweber B
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):449-61. PubMed ID: 6289397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrocortisone choleresis in the dog.
    Macarol V; Morris TQ; Baker KJ; Bradley SE
    J Clin Invest; 1970 Sep; 49(9):1714-23. PubMed ID: 5449708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
    Conway JG; Neptun DA; Garvey LK; Popp JA
    Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of insulin on bile-salt-independent canalicular secretion.
    Snow JR; Jones RS
    Surgery; 1978 Apr; 83(4):458-63. PubMed ID: 635782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
    Seifert J; Mostecká H
    Carcinogenesis; 1988 Jan; 9(1):3-8. PubMed ID: 2446797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adrenergic antigonists on prereplicative changes during nafenopin-induced liver growth in the rat.
    Lam DC; Levine WG
    Biochem Pharmacol; 1979 Dec; 28(24):3539-44. PubMed ID: 533557
    [No Abstract]   [Full Text] [Related]  

  • 38. Primate biliary physiology. 8. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition.
    Redinger RN; Small DM
    J Clin Invest; 1973 Jan; 52(1):161-72. PubMed ID: 4629906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids.
    Miyai K; Richardson AL; Mayr W; Javitt NB
    Lab Invest; 1977 Mar; 36(3):249-58. PubMed ID: 839737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma clearance rate of thyroxine despite decreased 5'-monodeiodination: study with a peroxisome proliferator in the rat.
    Kaiser CA; Seydoux J; Giacobino JP; Girardier L; Burger AG
    Endocrinology; 1988 Mar; 122(3):1087-93. PubMed ID: 3342745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.